Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Earendil Labs is a biotechnology company developing technology platforms that transform therapeutic protein discovery.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Waiv is an AI precision medicine company with a vision to find the right drug for every patient.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Sanofi has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Earendil Labs received $787.0M in a Venture - Series Unknown round. Sanofi's total known invested capital is $5.5B.
Sanofi's average investment size is $112.3M across its portfolio of 129 companies.
Recent Sanofi portfolio additions include Earendil Labs, SAB Biotherapeutics, Curevo, Latigo Biotherapeutics, Waiv. These companies were founded in 2020 or later.